MedPath
NMPA Approval

Bimekizumab Injection

国药准字SJ20240030

July 16, 2024

Drug Information

比奇珠单抗注射液

倍捷乐

注射剂

预充式注射器装:160mg(1.0ml)/支

生物制品

July 16, 2024

July 15, 2029

Company Information

Applicant Company

UCB-Pharma SA

Allée de la Recherche 60, B-1070 Bruxelles, Belgium

Manufacturing Company

UCB-Pharma SA

Chemin du Foriest, 1420 Braine l’Alleud, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

比奇珠单抗注射液 - NMPA 批准文号 | MedPath